Wanleng Deng

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays.

Yiling Lu, Jun Li, Rehan Akbani, 2017, Cancer cell.

ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties

Michael A. Davies, C. Lovly, Huiqin Chen, 2018, Molecular Cancer Research.

Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma

Victor G Prieto, Jeffrey E Gershenwald, Gordon B Mills, 2009, Clinical Cancer Research.

Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma.

Kakajan Komurov, Gordon B Mills, Prahlad T. Ram, 2014, Cancer research.

Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.

Ping Zhang, Yiling Lu, Gordon B Mills, 2003, Molecular endocrinology.

Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma

Michael A. Davies, Chaan S. Ng, Roland L. Bassett, 2012, Clinical Cancer Research.